Katy de Valle
Katy de Valle
Top Publications
- Billich, N, Bray, P, Truby, H, Evans, M, Carroll, K, de Valle, K, Adams, J, Kennedy, RA, Villano, D, Kornberg, AJ, et al. Pilot study of a virtual weight management program for Duchenne muscular dystrophy.. Muscle Nerve 69(4) : 459 -466 2024 view publication
- Billich, N, Bray, P, Truby, H, Evans, M, Ryan, MM, Carroll, K, de Valle, K, Villano, D, Kornberg, A, Sowerby, B, et al. Exploring caregivers' attitudes and beliefs about nutrition and weight management for young people with Duchenne muscular dystrophy.. Muscle Nerve 69(4) : 448 -458 2024 view publication
- Woodcock, I, Tachas, G, Desem, N, Houweling, P, Yiu, E, Kean, M, Emmanuel, J, Kennedy, R, Carroll, K, de Valle, K, et al. A Phase 2 open-label study to determine the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy. 2024 view publication
- Woodcock, IR, Tachas, G, Desem, N, Houweling, PJ, Kean, M, Emmanuel, J, Kennedy, R, Carroll, K, de Valle, K, Adams, J, et al. A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice.. PLoS One 19(1) : e0294847 2024 view publication
- Montagnese, F, de Valle, K, Lemmers, RJLF, Mul, K, Dumonceaux, J, Voermans, N, 268th ENMC workshop participants. 268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trials.. Neuromuscul Disord 33(5) : 447 -462 2023 view publication
Page 1 of 7